you are here: HomeNewsBiontech
biontech
Jump to
51 Results Found
  • BioNTech says 'no evidence' its jabs need adapting for variants May 10, 2021 05:57 PM IST

    BioNTech says 'no evidence' its jabs need adapting for variants

    BioNTech chief executive Ugur Sahin had said in April that the vaccine works against the Indian variant.

  • COVID-19 Vaccines | China’s Fosun Pharma signs deal for 1 billion vaccines with BioNTech May 10, 2021 01:35 PM IST

    COVID-19 Vaccines | China’s Fosun Pharma signs deal for 1 billion vaccines with BioNTech

    The vaccine has yet to be approved in mainland China, where regulations require an in-country clinical trial. BioNTech’s CEO has said the company expects the shot to be approved in July.

  • Europe will reach herd immunity by August: BioNTech Chief Ugur Sahin Apr 28, 2021 06:12 PM IST

    Europe will reach herd immunity by August: BioNTech Chief Ugur Sahin

    While the exact threshold required to reach that critical level of immunization remains a matter of debate, experts say a level above 70 percent would significantly disrupt transmission of the coronavirus within a population.

  • Pfizer asks United States to allow more kids to get vaccine Apr 10, 2021 09:02 AM IST

    Pfizer asks United States to allow more kids to get vaccine

    New York-based Pfizer and BioNTech SE of Germany have asked the US Food and Drug Administration to expand the emergency use authorisation for their vaccine to include adolescents ages 12 through 15.

  • BioNTech raises COVID vaccine output goal to 2.5 billion doses Mar 30, 2021 04:31 PM IST

    BioNTech raises COVID vaccine output goal to 2.5 billion doses

    The company said the boost would allow it to "address increased demand" as countries around the world race to contain new, more contagious virus variants.

  • Scientist behind coronavirus shot says next target is cancer Mar 19, 2021 08:15 PM IST

    Scientist behind coronavirus shot says next target is cancer

    Ozlem Tureci, who founded the German company BioNTech with her husband Ugur Sahin, was working on a way to harness the body’s immune system to tackle tumors when they learned last year of an unknown virus infecting people in China.

  • Pfizer requirements causing delays in COVAX deliveries: GAVI Mar 02, 2021 07:49 PM IST

    Pfizer requirements causing delays in COVAX deliveries: GAVI

    Seth Berkley, CEO of the GAVI alliance that co-leads the COVAX multilateral vaccine facility with the World Health Organization (WHO), told journalists the requirements were partly related to indemnification issues.

  • Coronavirus | Germans clamour for COVID-19 vaccines, but shun AstraZeneca’s offering Feb 26, 2021 02:57 PM IST

    Coronavirus | Germans clamour for COVID-19 vaccines, but shun AstraZeneca’s offering

    Many people — including health workers — are skipping appointments or refusing to sign up for the AstraZeneca shot, which they fear is less effective than the Pfizer-BioNTech vaccine

  • Pfizer submits data showing COVID-19 vaccine's stability in refrigerators Feb 19, 2021 07:12 PM IST

    Pfizer submits data showing COVID-19 vaccine's stability in refrigerators

    Pfizer/BioNTech’s vaccine, along with Moderna Inc’s two-dose vaccine, won the U.S. emergency use authorization (EUA) and is being widely distributed as part of the country’s mass vaccination efforts.

  • COVID-19 vaccine update | Israeli study finds Pfizer vaccine 85% effective after first shot Feb 19, 2021 06:28 PM IST

    COVID-19 vaccine update | Israeli study finds Pfizer vaccine 85% effective after first shot

    The Sheba Medical Center's findings compare with overall efficacy of around 95% in a two dose regimen 21 days apart for the shot developed with Germany's BioNTech.

  • COVID-19 Vaccine update | EU pressures AstraZeneca to deliver vaccines as promised Jan 26, 2021 03:19 PM IST

    COVID-19 Vaccine update | EU pressures AstraZeneca to deliver vaccines as promised

    AstraZeneca's announcement that it will deliver fewer vaccines to the EU early on has only increased pressure on the 27-nation bloc, especially since Pfizer-BioNTech, the first vaccine to get EU approval, failed last week to keep up its promised deliveries to the EU.

  • COVID-19 vaccine update | Pfizer wants India to order coronavirus vaccine before pursuing approval Jan 25, 2021 08:56 PM IST

    COVID-19 vaccine update | Pfizer wants India to order coronavirus vaccine before pursuing approval

    India's CDSCO says Pfizer officials failed to turn up to meetings after the company's application was made in early December. The regulator has also declined to accept the company's request for approval without a small local trial on the vaccine's safety and immunogenicity for Indians

  • Pfizer-BioNTech vaccine appears effective against UK COVID-19 strain: Study Jan 20, 2021 04:15 PM IST

    Pfizer-BioNTech vaccine appears effective against UK COVID-19 strain: Study

    The research team led by BioNTech Chief Executive Officer Ugur Sahin has said the result of the study proves it is very unlikely that the UK variant viruses will be able to dodge the Pfizer COVID-19 vaccine.

  • Vaccine rollout delayed in Europe as global COVID deaths near 2 million Jan 15, 2021 10:25 PM IST

    Vaccine rollout delayed in Europe as global COVID deaths near 2 million

    At the Meissen crematorium in Germany's Saxony state, coffins were stacked up to three high, or even stored in hallways, awaiting cremation.

  • BioNTech aims for 2 billion COVID-19 vaccine doses in 2021 Jan 11, 2021 07:45 PM IST

    BioNTech aims for 2 billion COVID-19 vaccine doses in 2021

    "We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label," BioNTech said in a presentation.

  • BioNTech warns against delaying second vaccine dose Jan 05, 2021 06:12 PM IST

    BioNTech warns against delaying second vaccine dose

    BioNTech, which developed the vaccine with US giant Pfizer, said its clinical data showing 95 percent efficacy was based on a two-dose schedule separated by 21 days.

  • Finland, Mexico report adverse effects to Pfizer vaccine; Argentina sees reactions to Sputnik V: Report Jan 03, 2021 08:57 AM IST

    Finland, Mexico report adverse effects to Pfizer vaccine; Argentina sees reactions to Sputnik V: Report

    A 32-year-old doctor in Mexico has been admitted to the intensive care unit (ICU) due to severe medical allergy to the Pfizer-BioNTech vaccine

  • Lack of approval for other COVID-19 vaccines by EU causing supply gaps, says BioNTech Jan 02, 2021 08:55 AM IST

    Lack of approval for other COVID-19 vaccines by EU causing supply gaps, says BioNTech

    Eyebrows have been raised in Germany where inoculation drives had to be halted due to the late rollout – despite the COVID-19 vaccine being indigenously developed.

  • Pfizer and BioNTech to offer COVID-19 vaccine to volunteers who got placebo Jan 02, 2021 05:20 AM IST

    Pfizer and BioNTech to offer COVID-19 vaccine to volunteers who got placebo

    Trial participants who received the placebo will have two doses of the investigational vaccine reserved for them within the study, the companies said on the website.

  • Despite hi-tech advances, many Europeans wary of taking COVID shot Dec 27, 2020 10:46 PM IST

    Despite hi-tech advances, many Europeans wary of taking COVID shot

    But surveys have pointed to high levels of hesitancy towards inoculation in countries from France to Poland, with many used to vaccines taking decades to develop, not just months.

  • From the lab to the jab: How BioNTech-Pfizer won the vaccine race Dec 27, 2020 08:17 PM IST

    From the lab to the jab: How BioNTech-Pfizer won the vaccine race

    Amid the global scramble to solve the problem of keeping vaccines at the right temperature as they get transported across the world, it would appear that there is a German company for every obscure application.

  • BioNTech CEO Ugur Sahin says will work with others to boost vaccine capacity: Report Dec 26, 2020 10:47 PM IST

    BioNTech CEO Ugur Sahin says will work with others to boost vaccine capacity: Report

    Sahin repeated BioNTech aimed to distribute 1.3 billion doses of its vaccine by the end of 2021 and that 70 percent of the world needed to be vaccinated by next winter to go back to "normal life".

  • BioNTech-Pfizer vaccine heads to EU as effectiveness against new strain tested Dec 22, 2020 04:00 PM IST

    BioNTech-Pfizer vaccine heads to EU as effectiveness against new strain tested

    The European Union is gearing up for a vaccination campaign of unprecedented scale following regulatory approval for the shot on Monday.

  • Explainer: How Moderna's COVID-19 vaccine stacks up against Pfizer/BioNTech's Dec 19, 2020 10:25 AM IST

    Explainer: How Moderna's COVID-19 vaccine stacks up against Pfizer/BioNTech's

    Both the Pfizer/BioNTech and Moderna's COVID-19 vaccines target the crown-like spikes on the surface of the novel coronavirus that it uses to break into healthy human cells. So, how are they different?

  • China's Fosun Pharma to import 100 million BioNTech vaccine doses Dec 16, 2020 03:21 PM IST

    China's Fosun Pharma to import 100 million BioNTech vaccine doses

    China has been rapidly developing its own COVID-19 vaccine candidates and ramping up production facilities, but local firms have also been partnering with foreign developers to supply the world's most populous country.

Sections